Larvol Delta - Group-revenue-and-EBITDA-in-line-with-expectations--FYB202-revenue-contributions-reflect-a-successful-market-launch

Ahzantive (aflibercept-mrbb) - Amneal, Formycon, Coherus Biosci, Klinge Pharma, Teva, MS Pharma, Alvogen

Cimerli (ranibizumab-eqrn) - Amneal, Formycon, Coherus Biosci, Teva

Otulfi (ustekinumab-aauz) - Formycon, Fresenius Kabi

https://firstwordpharma.com/story/5959639

May 12, 2025